OnKure Therapeutics Inc. (OKUR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear

OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
3.00
0.29 (10.70%)
At close: Oct 06, 2025, 10:11 AM

OnKure Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.18 -6.27 -10.53 -3.9
PEG Ratio
-0.04 -0.31 0.12 -0.02
PS Ratio
n/a n/a n/a n/a
PB Ratio
1.10 -2.17 -5.71 1.05
P/FCF Ratio
-2.24 -6.36 -11.07 -4.06
P/OCF Ratio
-2.24 -6.41 -11.53 -4.08
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.01 -0.01 -0.01 n/a
Quick Ratio
10.73 4.64 2.46 24.79
Current Ratio
10.73 4.64 2.46 24.79
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-181.29 n/a n/a n/a
Return on Equity
-0.51 0.35 0.54 -0.27
Return on Assets
-0.46 -0.99 -1.84 -0.26
Return on Invested Capital
-0.52 -1.28 -2.7 -0.27
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a